Inhaled epoprostenol for management of acute respiratory failure and pulmonary vascular disease
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Inhaled epoprostenol offers a localized prostacyclin delivery for cardiopulmonary conditions, minimizing systemic side effects. While not improving outcomes in severe acute respiratory distress syndrome, it shows promise in managing pulmonary hypertension and select patient groups.
Area Of Science
- Cardiopulmonary Medicine
- Pharmacology
Background
- Inhaled epoprostenol provides targeted prostacyclin delivery, mitigating ventilation-perfusion abnormalities.
- Systemic administration of prostacyclin can cause adverse effects, making inhaled routes attractive.
Purpose Of The Study
- To review the pharmacologic properties and clinical applications of inhaled epoprostenol.
- To outline its use in acute hypoxemic respiratory failure and pulmonary vascular disease.
Main Methods
- Literature review of studies on inhaled epoprostenol.
- Analysis of its efficacy in acute respiratory distress syndrome and pulmonary hypertension.
Main Results
- Inhaled epoprostenol did not improve outcomes (ventilator-free days, ICU stay, mortality) in ARDS patients requiring mechanical ventilation.
- It may offer benefits in specific ARDS patient subsets.
- In pulmonary hypertension, it supports chronic therapy and may improve right ventricular function.
Conclusions
- Inhaled epoprostenol is a viable option for targeted prostacyclin delivery in cardiopulmonary diseases.
- Its role in ARDS is limited, but it is a valuable adjunct in pulmonary hypertension management.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Primary Step: The most critical intervention for all COPD patients who smoke.
Benefits: Slows disease...
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...